Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Reexamining the research exemption

Nature Biotechnology volume 23, pages 659–661 (2005)Cite this article

The US Supreme Court is considering the reach of patents into basic research. If it decides to exempt a broad swathe of research, the biotech industry could lose millions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. McDermott Will & Emery LLP, 18191 Von Karman Avenue, Irvine, CA, USA

    Mauricio A Flores & Cathryn Campbell

Author notes

  1. Mr. Flores argued on behalf of Integra LifeSciences before the Supreme Court on April 20, 2005.

    Authors
    1. Mauricio A Flores
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Cathryn Campbell
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Cathryn Campbell.

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Flores, M., Campbell, C. Reexamining the research exemption. Nat Biotechnol 23, 659–661 (2005). https://doi.org/10.1038/nbt0605-659

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1038/nbt0605-659

    Search

    Advanced search

    Quick links

    Nature Briefing

    Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

    Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing